Oak Associates’s Cerence CRNC Stock Holding History

Oak Associates’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,625	Closed	-$394K	–	133
2022 Q2	$394K	Hold	15,625	–	–	0.03%	120
2022 Q1	$564K	Buy	15,625 +6,395	+69%	+$315K	0.03%	119
2021 Q4	$707K	Buy	+9,230	New	+$814K	0.04%	112

Other funds holding CRNC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

CCPM

Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Oak Associates's CRNC Position: Q3 2022 in Review

Oak Associates sold out of Cerence (CRNC) in Q3 2022, closing a stake of 15,625 shares — an estimated $394K sold.

Oak Associates first reported a position in CRNC in Q4 2021 and held it in 3 quarters. The position peaked at $707K in Q4 2021. 230 funds tracked by Wall St. Rank hold CRNC as of Q3 2022.

Oak Associates reported no remaining Cerence position as of Q3 2022 after selling out during the quarter.
Oak Associates sold 15,625 Cerence shares in Q3 2022, an estimated $394K.
Oak Associates first reported a position in Cerence in Q4 2021 and held it in 3 quarters.
Oak Associates's Cerence position peaked at $707K in Q4 2021.
230 funds tracked by Wall St. Rank held Cerence as of Q3 2022.

Based on Oak Associates's 13F filing for Q3 2022, filed 9 Nov 2022.